Nightingale Health

Nightingale's major research projects will generate revenue in H2.

We expect revenue to grow, driven by research projects and the Terveystalo collaboration.

The New York laboratory permit allows tests to be offered to healthcare providers without separate FDA approval.

The North Karelia wellbeing services county is piloting Nightingale's blood analysis technology.

A new study shows that the company's blood test can improve the detection of risk factors for heart attacks and strokes.

14:40

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

In light of the news, Nightingale is rebuilding its management team to better accelerate growth in its healthcare business.

The rapid change came as a surprise to us and appears to have occurred at the company's initiative, although the exact reasons remain unclear due to the concise announcement.

With the new agreement, Nightingale's blood analysis technology will be made available to all Terveystalo customer groups, whereas previously it has mainly been used in health check-ups for occupational health customers.